ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q3 2021. The put-call ratio across all filers is 0.36 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $405,661 | +7.6% | 14,947 | +42.9% | 0.00% | – |
| Q1 2023 | $376,945 | -92.6% | 10,462 | -91.9% | 0.00% | -100.0% |
| Q4 2022 | $5,083,050 | -14.2% | 128,619 | -12.7% | 0.01% | -25.0% |
| Q3 2022 | $5,921,000 | -54.9% | 147,370 | -52.8% | 0.01% | -50.0% |
| Q2 2022 | $13,121,000 | +8.7% | 312,118 | +0.7% | 0.02% | +33.3% |
| Q1 2022 | $12,073,000 | -38.5% | 309,882 | -37.1% | 0.01% | -36.8% |
| Q4 2021 | $19,638,000 | +19.5% | 492,794 | +8.3% | 0.02% | +5.6% |
| Q3 2021 | $16,440,000 | -17.6% | 454,894 | -6.6% | 0.02% | -18.2% |
| Q2 2021 | $19,963,000 | -15.2% | 487,022 | -9.8% | 0.02% | -24.1% |
| Q1 2021 | $23,551,000 | -22.5% | 539,906 | -11.1% | 0.03% | -27.5% |
| Q4 2020 | $30,386,000 | – | 607,115 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |